ArticleNaunyn-Schmiedeberg's archives of pharmacology2024

Dihydromyricetin alleviates inflammatory bowel disease associated intestinal fibrosis by inducing autophagy through the PI3K/AKT/mTOR signaling pathway.

XiaoChun Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.